Virtual Medicinal Product (VMP) - Risperidone 37.5mg powder and solvent for prolonged-release suspension for injection vials

Navigation

Name Details

Name Start Date End Date
Name Current Name Risperidone 37.5mg powder and solvent for prolonged-release suspension for injection vials Start Date 01-12-2024 End Date
Previous Name Previous Name Risperidone 37.5mg powder and solvent for suspension for injection vials Start Date 09-06-2004 End Date 30-11-2024
Abbreviated Name Abbreviated Name Risperidone 37.5mg inj vials Start Date 01-05-2009
Previous Abbreviated Name Risperidone 37.5mg pdr & solv for susp for inj vials Previous Start Date 14-09-2004 Previous End Date 30-04-2009

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
1.0
UDFS UOM
vial
Unit Dose UOM
vial

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
No Controlled Drug Status
Route
Intramuscular
Form
Powder and solvent for prolonged-release suspension for inj
Ontology Form/Route
suspensioninjectionprolonged-release.intramuscular-deep
Name Basis
rINN - Recommended International Non-proprietary

Codes

ATC Code
N05AX08
BNF Start Date End Date
Current BNF 04020200 Start Date 04-04-2022 End Date
Previous BNF 04020200 Start Date 03-02-2005 End Date 03-04-2022
SNOMED Codes
Code Start Date End Date
4176911000001105 27-03-2003

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Risperidone Based on Ingredient Substance 37.5 mg

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
1 vial 11132 Part VIIIA Category C